NCT01647893View on ClinicalTrials.gov

Phase 1 Single Dose Escalation Study of CTB-001

PHASE1UnknownINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

CTB-001

IV bolus or IV infusion

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

HLB Pharmaceutical Co., Ltd.

INDUSTRY

NCT01647893 - Phase 1 Single Dose Escalation Study of CTB-001 | Biotech Hunter | Biotech Hunter